Sugentech Subsidiary Vespexx Hosts Korea’s First Global Femtech Summit, Accelerating U.S. Expansion

Sugentech’s in vitro diagnostics and femtech subsidiary Vespexx hosted Korea Femtech Summit 2026, Korea’s first global femtech event.

Held on June 30 at Seongam Art Hall in Seoul, the summit explored the global femtech market. Companies, investors, and experts discussed women’s healthcare across the life course, advances in hormone testing, and AI-powered healthcare services.

Drawing on its experience operating Signaling, a women’s health platform with 800,000 users across Asia, Vespexx introduced “Dyadic Health,” a concept in which couples manage their health together. It also presented its U.S. expansion strategy for Soonr, a couples-focused preconception health platform.

Kai Health, which develops AI-powered embryo analysis software, and Endo Health, an AI women’s healthcare startup backed by global venture capital firm a16z, also participated and shared their international expansion strategies. Sugentech introduced Surearly SMART, its preconception platform powered by hormone data.

Sugentech CEO Mi-jin Son said femtech is entering a new phase driven by AI, precision medicine, wearable devices, and hormone data platforms. She added that the company plans to expand technology and data partnerships while continuing to introduce innovative women’s health services.

Source: Edaily · By Ha-yeon Shin · Originally published in Korean · Published on July 1, 2026